Related Experiment Video
Updated: Oct 15, 2025

14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
16.0K
Circulating tumor cells in breast cancer
Eunice López-Muñoz1, Gabriel Enrique Mejía-Terrazas2
1Instituto Mexicano del Seguro Social, Hospital de Gineco Obstetricia No. 4 "Luis Castelazo Ayala", Unidad de Investigación Médica en Medicina Reproductiva.
Revista Medica Del Instituto Mexicano Del Seguro Social
|October 25, 2021
Summary
Distant breast cancer metastasis, a cause of mortality, originates from circulating tumor cells (CTCs). This review covers CTCs
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis Research
Background:
- Breast cancer is the most common cancer in women, with mortality primarily linked to distant metastases.
- Distant metastasis involves the spread of cancer cells from the primary tumor to remote sites.
- Circulating tumor cells (CTCs) in the blood are key indicators and precursors of metastatic disease.
Purpose of the Study:
- To review the molecular mechanisms underlying breast cancer metastasis.
- To explore current techniques for CTC enrichment, identification, and molecular characterization.
- To discuss the clinical utility and applications of CTC analysis in breast cancer patients, including perioperative management.
Main Methods:
- Literature review focusing on molecular aspects of metastasis.
- Analysis of techniques for CTC isolation and characterization (e.g., molecular profiling).
- Examination of clinical studies and case examples demonstrating CTC applications.
Main Results:
- CTCs serve as crucial biomarkers for metastasis and disease progression in breast cancer.
- Advanced techniques enable sensitive detection and detailed molecular analysis of CTCs.
- CTC analysis provides valuable insights for treatment strategies and perioperative care.
Conclusions:
- Understanding the molecular basis of CTCs is vital for combating breast cancer metastasis.
- Technological advancements in CTC detection enhance diagnostic and prognostic capabilities.
- The clinical application of CTCs holds significant promise for personalized breast cancer management.
Related Concept Videos
Metastasis
5.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
The Tumor Microenvironment
7.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K

